These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Guidelines for the management of patients with atrial fibrillation. Executive summary]. Fuster V; Rydén LE; Cannom DS; Crijns HJ; Curtis AB; Ellenbogen KA; Halperin JL; Le Heuzey JY; Neal Kay G; Lowe JE; Bertil Olsson S; Prystowsky EN; Tamargo JL; Wann S Rev Esp Cardiol; 2006 Dec; 59(12):1329. PubMed ID: 17194429 [No Abstract] [Full Text] [Related]
25. [On the strategy of treatment of atrial fibrillation in the elderly (a response to the article "Ciliary arrhythmia" by M. A. Gurevich)]. Rovinskiĭ VI Klin Med (Mosk); 2006; 84(9):65-6. PubMed ID: 17209452 [No Abstract] [Full Text] [Related]
26. [Atrial fibrillation frequency a possible prognostic support in atrial fibrillation. FAF analysis gives hope for better therapeutic choice]. Olsson SB; Platonov P; Holmqvist F; Bollmann A Lakartidningen; 2010 Aug 11-24; 107(32-33):1839-43. PubMed ID: 20873329 [No Abstract] [Full Text] [Related]
27. Facilitating internal cardioversion of chronic atrial fibrillation with ibutilide--predictors of atrial defibrillation-threshold decrease. Efremidis M; Sideris A; Batra R; Manolatos D; Xidonas S; Kardara D; Ekonomou D; Evagelou D; Filippatos G; Kardaras F Med Sci Monit; 2004 Jun; 10(6):CR258-63. PubMed ID: 15173670 [TBL] [Abstract][Full Text] [Related]
35. Contemporary approach to electrical and pharmacological cardioversion of atrial fibrillation. Rajagopalan B; Curtis AB Postgrad Med; 2012 Nov; 124(6):26-35. PubMed ID: 23322136 [TBL] [Abstract][Full Text] [Related]
36. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial. Kirchhof P; Fetsch T; Hanrath P; Meinertz T; Steinbeck G; Lehmacher W; Breithardt G Am Heart J; 2005 Nov; 150(5):899. PubMed ID: 16290956 [TBL] [Abstract][Full Text] [Related]
37. [Rate control or electrical cardioversion for persistent atrial fibrillation? Results of RACE]. Liakishev AA Kardiologiia; 2003; 43(6):73-4. PubMed ID: 12974273 [No Abstract] [Full Text] [Related]
38. 1:1 atrial flutter after vernakalant administration for atrial fibrillation cardioversion. de Riva-Silva M; Montero-Cabezas JM; Salgado-Aranda R; López-Gil M; Fontenla-Cerezuela A; Arribas-Ynsaurriaga F Rev Esp Cardiol (Engl Ed); 2012 Nov; 65(11):1062-4. PubMed ID: 22727797 [No Abstract] [Full Text] [Related]
39. [The use of antiarrhythmia agents to increase the probability of success of electric cardioversion in atrial fibrillation]. Mascitelli L; Pezzetta F Ital Heart J Suppl; 2002 May; 3(5):570; author reply 570-1. PubMed ID: 12064197 [No Abstract] [Full Text] [Related]
40. Atrial fibrillation. Finding the right treatment. Mayo Clin Health Lett; 2007 Jan; 25(1):1-3. PubMed ID: 17330342 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]